Brief: Cutia Therapeutics To Implement Share Repurchase Program From Oct 2 To Dec 31
30/09/2026 11:28
BRIEF-Cutia Therapeutics To Implement Share Repurchase Program From Oct 2 To Dec 31 Sept 30 (Reuters) - Cutia Therapeutics 2487.HK:
TO IMPLEMENT SHARE REPURCHASE PROGRAM FROM OCT 2 TO DEC 31, 2026
MAXIMUM FUNDS FOR REPURCHASE SET AT RMB30 MILLION, UP TO 36.3 MILLION SHARES
Further company coverage: 2487.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cutia Therapeutics
See all newsBrief: Cutia Therapeutics To Implement Share Repurchase Program From Oct 2 To Dec 31
Brief: Cutia Therapeutics Says Cu-40102 Bags Marketing Approval From Macao Pharmaceutical Administration Bureau
Brief: Cutia Therapeutics Says Nmpa Accepts Biologics License Application For Cu-20101
Brief: Cutia Therapeutics Posts HY Loss Of RMB180.4 MLN
Brief: Cutia Therapeutics Says CU-30101 Obtains Drug Marketing Authorization By NMPA China